In our study, the HFD-FGF6 mice exhibited an improved metabolism, reduced subcutaneous and visceral fat, relieved insulin resistance, elevated O2 consumption, and lower serum TG and NEFA levels, in comparison with those in the HFD-Ctrl group. This evidence concerns the gene FGF6 and Insulin resistance.